Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (16)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Gerber, C. M.
Right arrow Articles by Cottagnoud, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gerber, C. M.
Right arrow Articles by Cottagnoud, P.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Journal of Antimicrobial Chemotherapy (2000) 45, 63-68
© 2000 The British Society for Antimicrobial Chemotherapy

Evaluation of cefepime alone and in combination with vancomycin against penicillin-resistant pneumococci in the rabbit meningitis model and in vitro

Cynthia M. Gerbera, Marianne Cottagnoudb, Klaus Neftelb, Martin G. Täuberc and Philippe Cottagnouda,*

a Department of Internal Medicine, Inselspital, 3010 Berne; b Department of Internal Medicine, Zieglerspital, 3007 Berne; c Institute of Medical Microbiology, University of Berne, Berne, Switzerland

Cefepime, a broad-spectrum, fourth-generation cephalosporin, showed excellent CSF penetration with levels ranging between 10 and 16 mg/L after two intravenous injections (100 mg/kg). The bactericidal activity of cefepime (–0.60 ± 0.28 {Delta}log10 cfu/mL/h) was superior to that of ceftriaxone (–0.34 ± 0.23 {Delta}log10 cfu/mL/h, P < 0.05) and vancomycin (–0.39 ± 0.19 {Delta}log10 cfu/mL/h, P < 0.05) in the treatment of rabbits with meningitis caused by an isolate highly resistant to penicillin (MIC of penicillin G: 4 mg/L). The addition of vancomycin to both cephalosporins did not significantly increase the killing rate compared with monotherapies (P > 0.05). Similar results were obtained in time–killing experiments in vitro.

* Corresponding author. Tel: +41-31-632-2111; Fax: +41-31-632-3847; E-mail: pcottagn{at}insel.ch


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 J Antimicrob ChemotherHome page
P. Gerber, A. Stucki, F. Acosta, M. Cottagnoud, and P. Cottagnoud
Daptomycin is more efficacious than vancomycin against a methicillin-susceptible Staphylococcus aureus in experimental meningitis
J. Antimicrob. Chemother., April 1, 2006; 57(4): 720 - 723.
[Abstract] [Full Text] [PDF]

Home page
 J Antimicrob ChemotherHome page
L. Flatz, M. Cottagnoud, F. Kuhn, J. Entenza, A. Stucki, and P. Cottagnoud
Ceftriaxone acts synergistically with levofloxacin in experimental meningitis and reduces levofloxacin-induced resistance in penicillin-resistant pneumococci
J. Antimicrob. Chemother., February 1, 2004; 53(2): 305 - 310.
[Abstract] [Full Text] [PDF]

Home page
 Antimicrob. Agents Chemother.Home page
F. Kuhn, M. Cottagnoud, F. Acosta, L. Flatz, J. Entenza, and P. Cottagnoud
Cefotaxime Acts Synergistically with Levofloxacin in Experimental Meningitis Due to Penicillin-Resistant Pneumococci and Prevents Selection of Levofloxacin-Resistant Mutants In Vitro
Antimicrob. Agents Chemother., August 1, 2003; 47(8): 2487 - 2491.
[Abstract] [Full Text] [PDF]

Home page
 Antimicrob. Agents Chemother.Home page
P. Cottagnoud, F. Acosta, M. Cottagnoud, and M. G. Tauber
Gemifloxacin Is Efficacious against Penicillin-Resistant and Quinolone-Resistant Pneumococci in Experimental Meningitis
Antimicrob. Agents Chemother., May 1, 2002; 46(5): 1607 - 1609.
[Abstract] [Full Text] [PDF]

Home page
 J Antimicrob ChemotherHome page
P. Cottagnoud, F. Acosta, M. Cottagnoud, and M. G. Tauber
Cefepime is efficacious against penicillin- and quinolone-resistant pneumococci in experimental meningitis
J. Antimicrob. Chemother., February 1, 2002; 49(2): 327 - 330.
[Abstract] [Full Text] [PDF]

Home page
 Antimicrob. Agents Chemother.Home page
P. Cottagnoud, F. Acosta, M. Cottagnoud, M. Pfister, and M. G. Tauber
Efficacies of BMS 284756 against Penicillin-Sensitive, Penicillin-Resistant, and Quinolone-Resistant Pneumococci in Experimental Meningitis
Antimicrob. Agents Chemother., January 1, 2002; 46(1): 184 - 187.
[Abstract] [Full Text] [PDF]

Home page
 J Antimicrob ChemotherHome page
M. Perrig, F. Acosta, M. Cottagnoud, C. M. Gerber, M. G. Tauber, and P. Cottagnoud
Efficacy of gatifloxacin alone and in combination with cefepime against penicillin-resistant Streptococcus pneumoniae in a rabbit meningitis model and in vitro
J. Antimicrob. Chemother., May 1, 2001; 47(5): 701 - 704.
[Abstract] [Full Text] [PDF]

Home page
 J Antimicrob ChemotherHome page
C. M. Gerber, L. Tovar, M. Cottagnoud, K. A. Neftel, M. G. Tauber, and P. Cottagnoud
Grepafloxacin against penicillin-resistant pneumococci in the rabbit meningitis model
J. Antimicrob. Chemother., August 1, 2000; 46(2): 249 - 253.
[Abstract] [Full Text] [PDF]

Home page
 Antimicrob. Agents Chemother.Home page
P. Cottagnoud, F. Acosta, M. Cottagnoud, K. Neftel, and M. G. Täuber
Synergy between Trovafloxacin and Ceftriaxone against Penicillin-Resistant Pneumococci in the Rabbit Meningitis Model and In Vitro
Antimicrob. Agents Chemother., August 1, 2000; 44(8): 2179 - 2181.
[Abstract] [Full Text]


Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.